Clinical Trial

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Study acronym: BEAT-BK
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
BEAT-BK will see the effect of immunosuppression reduction/modification with and without IVIG on BKPyV infection, allograft function, allograft loss, acute transplant rejection, immunosuppression load and death in kidney and simultaneous kidney pancreas transplant recipients with polyomavirus infections (BKPyV).
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-04-04; most recent amendment 2026-06-05.
Status change: Not Yet Recruiting → Recruiting 2023-09-04
Trial Details
NCT Number NCT05325008
Lead Sponsor The University of Queensland
Conditions BK Viremia, Kidney Transplant Infection, Kidney Transplant Failure and Rejection
Enrollment 280 participants
Start Date 2023-08-18
Primary Completion 2027-08-01 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-08